The new intermittent catheter Luja™ addresses important risk factors for urinary tract infections, a significant burden for people using intermittent catheters as well as healthcare systems as a whole ...

Intermittent catheterisation (IC) remains a pivotal intervention in managing neurogenic bladder dysfunction among spinal cord injury patients. By facilitating periodic bladder emptying, IC helps to ...

The use of a hydrophilic-coated catheter called SpeediCath (Coloplast) delays the onset of urinary tract infections (UTIs) in patients with acute spinal cord injury. Compared with the use of an ...

Coloplast A/S is about to launch a new single-use male intermittent catheter featuring new technology designed to reduce the risk of urinary tract infections (UTI). “The Luja device, with its ...